TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12504048

Group type: EXPERIMENTAL
Intervention: RT plus TAM
Number of subjects: 86

Group type: COMPARATOR
Intervention: TAM alone
Number of subjects: 86
Study: 10812042

Group type: EXPERIMENTAL
Intervention: 35% CO2/65% O2 challenge
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control subjects (matched for age and gender)
Number of subjects: 50
Study: 7855383

Group type: EXPERIMENTAL
Intervention: Insulin and nicotinamide (3 g/day for 1 year)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 21
Study: 2671502

Group type: EXPERIMENTAL
Intervention: MALG (antilymphoblast globulin)
Number of subjects: 42

Group type: COMPARATOR
Intervention: ATGAM (antithymocyte globulin)
Number of subjects: 42
Study: 1018027

Group type: EXPERIMENTAL
Intervention: In-patient rest in bed (IP) for six months followed by out-patient treatment
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Ambulatory out-patient treatment (OP) from the start
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Out-patient treatment with a plaster-of-Paris jacket (J) for nine months
Number of subjects: 350

Group type: COMPARATOR
Intervention: Ambulatory treatment without any support (No J)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Chemotherapy with PAS and isoniazid for eighteen months supplemented with streptomycin for the first three months (SPH)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Chemotherapy with PAS and isoniazid for eighteen months without the supplement (PH)
Number of subjects: 350
Study: 31033046

Group type: EXPERIMENTAL
Intervention: 10 mL flush volume
Number of subjects: 55

Group type: COMPARATOR
Intervention: 3 mL flush volume
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 6 hourly flushing frequency
Number of subjects: 55

Group type: COMPARATOR
Intervention: 24 hourly flushing frequency
Number of subjects: 55
Study: 30728037

Group type: EXPERIMENTAL
Intervention: Surgical workforce (number of surgical, anesthetic, and obstetric physician providers)
Number of subjects: 3014

Group type: EXPERIMENTAL
Intervention: Regional referral hospitals
Number of subjects: 3014

Group type: COMPARATOR
Intervention: General hospitals
Number of subjects: 3014

Group type: EXPERIMENTAL
Intervention: Cesarean sections
Number of subjects: 3014
Study: 29116299

Group type: EXPERIMENTAL
Intervention: Ketac Molar EasyMix (3M ESPE)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Vitro Molar (DFL)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 117
Study: 26363970

Group type: EXPERIMENTAL
Intervention: lorazepam (LRZ)
Number of subjects: 27

Group type: COMPARATOR
Intervention: saline
Number of subjects: 27
Study: 23100191

Group type: EXPERIMENTAL
Intervention: Endoscopic release
Number of subjects: 52

Group type: COMPARATOR
Intervention: Mini-incision release
Number of subjects: 52
Study: 20606150

Group type: EXPERIMENTAL
Intervention: Tight control (systolic BP < 130 mm Hg)
Number of subjects: 6400

Group type: COMPARATOR
Intervention: Usual control (systolic BP 130 mm Hg to < 140 mm Hg)
Number of subjects: 6400

Group type: COMPARATOR
Intervention: Uncontrolled (systolic BP ≥ 140 mm Hg)
Number of subjects: 6400

Group type: EXPERIMENTAL
Intervention: Tight control
Number of subjects: 6400

Group type: COMPARATOR
Intervention: Usual control
Number of subjects: 6400

Group type: EXPERIMENTAL
Intervention: Tight control (extended follow-up)
Number of subjects: 6400

Group type: COMPARATOR
Intervention: Usual control (extended follow-up)
Number of subjects: 6400
Study: 18202964

Group type: EXPERIMENTAL
Intervention: Continuous combined conjugated estrogens (CE)/medroxyprogesterone acetate (MPA) at doses of 0.625/2.5 mg/day, 0.45/1.5 mg/day, and 0.3/1.5 mg/day for 6 months (6 continuous 28-day cycles)
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 1028
Study: 16363019

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 274

Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 274
Study: 14653291

Group type: EXPERIMENTAL
Intervention: Classical sealants
Number of subjects: 102

Group type: COMPARATOR
Intervention: Flowable composites
Number of subjects: 102

Group type: COMPARATOR
Intervention: Flowable compomers
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Conventional etching with phosphoric acid
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Agitating the etchant
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Fissure types
Number of subjects: 102
Study: 10985715

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (TT)
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: TT + IABP
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: IABP only
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: TT only
Number of subjects: 856

Group type: COMPARATOR
Intervention: No TT, no IABP
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Early IABP (< or = 6 h after TT)
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Late IABP
Number of subjects: 856
Study: 9417486

Group type: EXPERIMENTAL
Intervention: Selenium substitution (Se+)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (Se-)
Number of subjects: 42
Study: 8245998

Group type: EXPERIMENTAL
Intervention: CBC ConstaVac reinfusion system (57 patients: 35 TKAs and 22 THAs)
Number of subjects: 111

Group type: COMPARATOR
Intervention: ConstaVac collection unit (54 patients: 34 TKAs and 20 THAs)
Number of subjects: 111
Study: 2937625

Group type: EXPERIMENTAL
Intervention: Thrombolysis alone (group I, 64 patients)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Thrombolysis and dilatation (group II, 63 patients)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Successful dilatation
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Failed dilatation
Number of subjects: 127
Study: 30617927

Group type: EXPERIMENTAL
Intervention: PGT-A group (n = 109)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Morphology group (n = 111)
Number of subjects: 220
Study: 29528692

Group type: EXPERIMENTAL
Intervention: Nerve growth factor injections
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isotonic saline injections
Number of subjects: 16
Study: 27230397

Group type: EXPERIMENTAL
Intervention: Single-gloved conditions
Number of subjects: 1466

Group type: COMPARATOR
Intervention: Double-gloved conditions
Number of subjects: 1466

Group type: COMPARATOR
Intervention: Double-gloved conditions with finer 4.0 suture
Number of subjects: 1466
Study: 25437217

Group type: EXPERIMENTAL
Intervention: Early nutritional support via the parenteral route
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early nutritional support via the enteral route
Number of subjects: 0
Study: 22796236

Group type: EXPERIMENTAL
Intervention: Spontaneous triggering of ovulation (spontaneous LH group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Administration of HCG (HCG group)
Number of subjects: 300
Study: 20114095

Group type: EXPERIMENTAL
Intervention: Spinal manipulation (8 treatments)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spinal manipulation (16 treatments)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Light massage (8 treatments)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Light massage (16 treatments)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Expectancy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patient-provider encounter (PPE)
Number of subjects: 80
Study: 18844804

Group type: EXPERIMENTAL
Intervention: Self-report measures tested for reliability and validity in populations of people with schizophrenia who use cannabis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biochemical tests for cannabis
Number of subjects: 0
Study: 15678399

Group type: COMPARATOR
Intervention: No covering of the eye (group 1)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Transparent eye shield for four hours (group 2)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Eye pad for four hours (group 3)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Eye pad until the next morning (group 4)
Number of subjects: 133
Study: 11919129

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Rosiglitazone (ROSI)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Both groups (PIO and ROSI)
Number of subjects: 186
Study: 10088734

Group type: EXPERIMENTAL
Intervention: Astigmatic keratotomy
Number of subjects: 95
Study: 8747677

Group type: EXPERIMENTAL
Intervention: Hypnotherapy (HT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Psychophysiological therapy (PP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (patients treated under general anesthesia)
Number of subjects: 22
Study: 2057400

Group type: EXPERIMENTAL
Intervention: Individual teaching using self-modeling in addition to a breast model
Number of subjects: 79

Group type: COMPARATOR
Intervention: Group teaching using only a breast model
Number of subjects: 79
Study: 6405490

Group type: EXPERIMENTAL
Intervention: 3-litre bag system
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional multiple-bottle system
Number of subjects: 10
Study: 31489910

Group type: EXPERIMENTAL
Intervention: 9 meals daily (9M)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 3 meals daily (3M)
Number of subjects: 18
Study: 30396619

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 26797700

Group type: EXPERIMENTAL
Intervention: Low-intensity plyometric exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-intensity plyometric exercise
Number of subjects: 24
Study: 25156992

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1224
Study: 23213288

Group type: EXPERIMENTAL
Intervention: Real rTMS combined with speech and language therapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham rTMS combined with speech and language therapy
Number of subjects: 26
Study: 20022345

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (Healthy Controls)
Number of subjects: 70
Study: 17923463

Group type: EXPERIMENTAL
Intervention: valsartan 320 mg
Number of subjects: 1188

Group type: COMPARATOR
Intervention: valsartan/hydrochlorothiazide 320 mg/12.5 mg
Number of subjects: 1188
Study: 15773961

Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Cyclosporine (CSA)
Number of subjects: 35
Study: 12127609

Group type: EXPERIMENTAL
Intervention: CK-MB measurements
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Troponin T measurements
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Troponin I measurements
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 222
Study: 10418646

Group type: EXPERIMENTAL
Intervention: Desflurane with N2O
Number of subjects: 60

Group type: COMPARATOR
Intervention: Desflurane without N2O (AIR-O2 mixture)
Number of subjects: 60
Study: 7552926

Group type: EXPERIMENTAL
Intervention: Salmeterol 42 micrograms twice daily
Number of subjects: 556

Group type: COMPARATOR
Intervention: Albuterol 180 micrograms four times daily
Number of subjects: 556

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556
Study: 2199801

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined therapy (Simvastatin + Cholestyramine)
Number of subjects: 60
Study: 374178

Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg daily for 3 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31461355

Group type: EXPERIMENTAL
Intervention: Morning serum cortisol (MSC)
Number of subjects: 306
Study: 31947163

Group type: EXPERIMENTAL
Intervention: Near Infrared (NIR) spectrometric monitoring of lactate levels using solution samples with varying concentrations of sodium lactate in isotonic Phosphate Buffer Solution (PBS) at pH 7.4.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: State-of-the-art spectrometer in the NIR region for lactate monitoring.
Number of subjects: 0
Study: 28757533

Group type: EXPERIMENTAL
Intervention: Carbonated water ingestion (CW)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Carbonated water sham-feeding (CW-SF)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Water ingestion (W)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Water sham-feeding (W-SF)
Number of subjects: 13
Study: 26467096

Group type: EXPERIMENTAL
Intervention: Weekly automated text messages (SMS-Track) reporting the number of days with bothersome LBP (0-7 days) over 1 year.
Number of subjects: 0
Study: 23354667

Group type: EXPERIMENTAL
Intervention: Experienced observers
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Naïve observers
Number of subjects: 14

Group type: COMPARATOR
Intervention: Real flash trials
Number of subjects: 14

Group type: COMPARATOR
Intervention: Illusory flash trials
Number of subjects: 14
Study: 22266771

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 863

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 863
Study: 21156747

Group type: EXPERIMENTAL
Intervention: Black tea with cheese fondue
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Water with cheese fondue
Number of subjects: 20

Group type: COMPARATOR
Intervention: White wine with cheese fondue
Number of subjects: 20

Group type: COMPARATOR
Intervention: Schnapps with cheese fondue
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both wine and schnapps
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tea
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dyspeptic symptoms
Number of subjects: 20
Study: 17290332

Group type: EXPERIMENTAL
Intervention: Anticoagulation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trauma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benign and malignant tumors of the adrenal gland
Number of subjects: 0
Study: 12920568

Group type: EXPERIMENTAL
Intervention: Thallium-201 muscle perfusion scan (Tl-201 muscle scan)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (healthy, age-matched women)
Number of subjects: 25
Study: 11137102

Group type: EXPERIMENTAL
Intervention: Garlic preparation (500 mg dehydrated garlic powder/day)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Garlic preparation (1000 mg dehydrated garlic powder/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 9853084

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 12
Study: 8061852

Group type: EXPERIMENTAL
Intervention: Spirapril (3, 6, 12, or 24 mg once daily)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Spirapril (all doses)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Spirapril
Number of subjects: 283

Group type: COMPARATOR
Intervention: Spirapril and Placebo
Number of subjects: 283
Study: 3243924

Group type: EXPERIMENTAL
Intervention: 3 mg prazosin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 6 mg prazosin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 12 mg prazosin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Higher dosage ranges (6 mg and 12 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 24
Study: 29698917

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Support Therapy (ST)
Number of subjects: 76
Study: 27022799

Group type: COMPARATOR
Intervention: Incentive Spirometry (IS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breathing retraining exercises by a physiotherapist
Number of subjects: 0
Study: 24041585

Group type: EXPERIMENTAL
Intervention: Walking with poles (2-point style)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Walking with poles (3-point style)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No poles
Number of subjects: 35
Study: 24418874

Group type: EXPERIMENTAL
Intervention: Dead-cells intake (n=15, viable cells were heat sterilized)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Viable-cells intake (n=14, 3.0×10⁵ colony-forming units of viable LAB cells per sample)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo intake (n=15, LAB removed from the pickles)
Number of subjects: 44
Study: 20868259

Group type: EXPERIMENTAL
Intervention: Laser Iridotomy (LI) in one eye
Number of subjects: 870

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 870
Study: 18809622

Group type: EXPERIMENTAL
Intervention: Multicomponent organizational intervention (TRANSLATE)
Number of subjects: 8405
Study: 16161729

Group type: EXPERIMENTAL
Intervention: EEG biofeedback protocol
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (additional time in treatment)
Number of subjects: 121
Study: 12892455

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EN) in D(+) patients (n=13)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EN) in D(-) patients (n=7)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Parenteral nutrition (PN) in D(+) patients (n=12)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Parenteral nutrition (PN) in D(-) patients (n=7)
Number of subjects: 39
Study: 10230189

Group type: EXPERIMENTAL
Intervention: Sertraline (average dose of 167 mg/day)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 8558315

Group type: EXPERIMENTAL
Intervention: Calcium carbonate co‐ingested with 40 g of a cereal product containing 16 g wheat bran
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium carbonate ingested without bran
Number of subjects: 0
Study: 1991366

Group type: EXPERIMENTAL
Intervention: Colestipol-niacin therapy plus diet
Number of subjects: 0
Study: 6576807

Group type: EXPERIMENTAL
Intervention: 3 mg vaginal prostaglandin E2 pessaries
Number of subjects: 36

Group type: COMPARATOR
Intervention: intravenous oxytocin
Number of subjects: 36
Study: 30478008

Group type: EXPERIMENTAL
Intervention: Valacyclovir (1.5 g BID)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 29687335

Group type: EXPERIMENTAL
Intervention: PF ophthalmic solution containing HA 0.4% and TAU 0.5%, QID
Number of subjects: 39

Group type: COMPARATOR
Intervention: PF ophthalmic solution containing HA 0.2%, QID
Number of subjects: 39

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 39
Study: 26802153

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine (nab-P + Gem)
Number of subjects: 257

Group type: COMPARATOR
Intervention: gemcitabine alone (Gem)
Number of subjects: 257
Study: 24205807

Group type: EXPERIMENTAL
Intervention: Electronic Diary (ED)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Food Diary (FD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 0
Study: 22278094

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) application
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 21146656

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration followed by PCI
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 5000
Study: 17071141

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lamotrigine (subset with mild depression)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (subset with mild depression)
Number of subjects: 70
Study: 15060773

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) assessment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard radiographs
Number of subjects: 35
Study: 12536591

Group type: EXPERIMENTAL
Intervention: 131I alone
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: 131I plus thyrostatic medication (PTU)
Number of subjects: 187
Study: 9696456

Group type: EXPERIMENTAL
Intervention: 20 mg morphine (p.o.)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 170 mg codeine (p.o.)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 7656919

Group type: EXPERIMENTAL
Intervention: Physostigmine (12.5 micrograms kg‐1) infused intravenously over 10 min
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Apomorphine (60 micrograms kg‐1) injected subcutaneously
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal saline (control test)
Number of subjects: 26
Study: 2526767

Group type: EXPERIMENTAL
Intervention: Nicotinamide 1 g/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 987761

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoimmunotherapy (cyclophosphamide, methotrexate, fluorouracil, and BCG vaccine +/− an irradiated allogeneic tumor cell vaccine)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoimmunotherapy
Number of subjects: 57
Study: 31895295

Group type: EXPERIMENTAL
Intervention: Light-intensity physical activity (5 min every 30 min)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Standing
Number of subjects: 129
Study: 29428266

Group type: EXPERIMENTAL
Intervention: Amniotic membrane allograft
Number of subjects: 16

Group type: COMPARATOR
Intervention: Temporal muscle fascia autograft
Number of subjects: 16
Study: 26865048

Group type: EXPERIMENTAL
Intervention: HZ/su (Shingrix) vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local injection site pain and swelling
Number of subjects: 0
Study: 25310928

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/day)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 23064870

Group type: EXPERIMENTAL
Intervention: Hypohydration (HYP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Euhydration (EUH)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exposure to 10 °C
Number of subjects: 32
Study: 19502599

Group type: EXPERIMENTAL
Intervention: Highest quartile of vitamin A
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Higher vitamin A levels
Number of subjects: 576